Table 2.
Univariate analysis for factors predicting major complications related to gastric conduit after TE
| Postoperative complications related to gastric conduit reconstruction | P-value | ||
|---|---|---|---|
| Negative (n = 52) | Positive (n = 23) | ||
| Age (years) | 62.9 ± 7.2 | 57.5 ± 8.7 | < 0.01 |
| Gender (Male, Female) | 37, 15 | 20, 3 | N.S. |
| BMI | 21.4 ± 2.7 | 21.1 ± 2.7 | N.S. |
| Preoperative chemotherapy | 21 (40.4%) | 13 (56.5%) | N.S. |
| TNM Stage (I, II, III, IV) | 22, 10, 18, 2 | 6, 9, 6, 2 | N.S. |
| Total operation time (min) | 604 ± 113 | 606 ± 116 | N.S. |
| Operation time of thoracic surgery (min) | 337 ± 77 | 318 ± 64 | N.S. |
| Blood loss (g) | 380 (303–623) | 340 (200–500) | N.S. |
| Blood Transfusion | 5 (9.6%) | 2 (5.2%) | N.S. |
| 3-field lymph node dissection | 12 (23.1%) | 11 (47.8%) | 0.03 |
| Paroxysmal atrial fibrillation | 10 (19.2%) | 3 (13.0%) | N.S. |
| Vasopressor agents | 5 (9.6%) | 3 (13.0%) | N.S. |
| WBC (10^3/μl) at 1POD | 9.7 (8.2–12.8) | 8.9 (7.0–11.5) | N.S. |
| CRP (10^4 μg/L) at 1POD | 8.7 ± 0.3 | 10.3 ± 0.5 | < 0.01 |
| Lactic acid (mmol/L) at 1POD | 1.4 (1.1–1,8) | 2.1 (1.2–2.7) | N.S. |
| CPK (IU/L) at 1POD | 890 (620–1309) | 1277 (675–2041) | 0.02 |
| Postoperative hospital stay (days) | 22 (19–28) | 39 (28–47) | < 0.01 |